| Hormonal and biochemical profiles of premenstrual syndrome. Treatment with essential fatty acids. | |
| | |
MedLine Citation:
|
PMID: 8392261 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Women diagnosed as suffering from premenstrual syndrome and symptom free controls were compared on hormonal parameters, glucose tolerance, mineralocorticoids, cholesterols, triglycerides, apolipoprotein (a), magnesium and calcium in the follicular and luteal phases of the menstrual cycle. The effect of treatment with essential fatty acids on the biochemical variables was also evaluated in a randomized, double-blind crossover design. The results showed that the hormonal and biochemical profiles of women with PMS and symptom free controls were markedly similar, except for aldosterone which was lower in the follicular and luteal phases and cholesterol which was higher in the follicular phase in women with PMS. No effects of treatment with essential fatty acids were found for any of the biochemical variables studied. |
| | |
Authors:
|
A Cerin; A Collins; B M Landgren; P Eneroth |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Acta obstetricia et gynecologica Scandinavica Volume: 72 ISSN: 0001-6349 ISO Abbreviation: Acta Obstet Gynecol Scand Publication Date: 1993 Jul |
Date Detail:
|
Created Date: 1993-08-12 Completed Date: 1993-08-12 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370343 Medline TA: Acta Obstet Gynecol Scand Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 337-43 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antilipemic Agents / therapeutic use* Cholesterol / blood Double-Blind Method Electrolytes / blood Fatty Acids, Essential / pharmacology*, therapeutic use* Female Follicular Phase Glucose Tolerance Test Gonadal Steroid Hormones / blood Humans Linoleic Acids Lipoprotein(a) / blood, drug effects Luteal Phase Mineralocorticoids / blood Plant Oils Premenstrual Syndrome / blood*, drug therapy*, physiopathology Severity of Illness Index Triglycerides / blood gamma-Linolenic Acid |
| Chemical | |
Reg. No./Substance:
|
0/Antilipemic Agents; 0/Electrolytes; 0/Fatty Acids, Essential; 0/Gonadal Steroid Hormones; 0/Linoleic Acids; 0/Lipoprotein(a); 0/Mineralocorticoids; 0/Plant Oils; 0/Triglycerides; 506-26-3/gamma-Linolenic Acid; 57-88-5/Cholesterol; 65546-85-2/Efamol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Changing concepts of medical treatment of endometriosis.
Next Document: Comparison of actual and ultrasound estimated second trimester gestational length in in-vitro fertil...